|
Cases
Here are some cases involving
the use of cetyl myristoleate from the author's practice.
Leona - She is a 64 year old
mother of five who has been developing degenerative changes in
her fingers over the last 15 years. She plays the piano frequently
and had to reduce the amount of playing time as a result of the
arthritis pain in her fingers. ANA titers have been mildly elevated
over the years and rheumatoid disease has been diagnosed in several
of her ancestors and one sibling. Leona's other medical problems
are mild hypertension and chronic sacro-lumbar pain which appears
to be attributable both to sciatic damage sustained in a water
skiing accident 24 years ago and Shunerman's disease as teenager.
Demonstrating both rheumatoid and osteoarthritis changes in her
fingers, she has a mild nodular deformity at the terminal joints
of the 3rd and 4th fingers on the left hand and fusiform swelling
in the medial and distal joints of most of her fingers. Her thumbs
were intermittently painful and swollen. She first took cetyl
myristoleate in mid-January, 1997. There is now increased range
of motion in all of the finger joints and visible reduction of
the rheumatoid-like swelling. The nodular deformities have not
changed noticeably. Her back problems demonstrated no improvement.
Her sedimentation rate has run from 15 to 35, and is currently
16, with her ANA <1:360. Leona is now able to play the piano
all she wants to without pain or swelling of her fingers.
Joyce - She is a 42 year old
mother of three and a court reporter in good general health,
suffering only from moderate hayfever in the spring. Recently
Joyce developed a generalized stiffness and soreness in her fingers,
which was worse on her right hand. The condition became so bad
over a couple of weeks that she began making numerous mistakes
in her court reporting and her speed was significantly reduced.
She was diagnosed with tenosynovitis. Joyce shows no deformities
of her hands associated with arthritis. She began a course of
cetyl myristoleate during the last week of February and finished
the last week of March, 1997. She reports complete restoration
of her dexterity with return of her normal accuracy and speed,
along with elimination of the associated pain.
Bob - He is a 67 year-old retired
politician who suffered lumbar and pelvic fractures in WWII when
his jeep struck a land mine. Over the years, these injuries produced
increasing pain, which seriously affected routine daily activities
like getting out of bed in the morning and his ability to play
golf. X-rays demonstrate degenerative arthritic changes in the
lumbar articulations and the right sacroiliac joint. At 6 feet
tall and 185 pounds, he is otherwise in good health. Bob has
been using anti-inflammatory drugs for over 20 years, including
Voltaren, ibuprofen, Tylenol, and aspirin. He took a one-half
course of 7.6 grams of cetyl myristoleate in September, 1996.
He experienced moderately severe inflammation (breakthrough pain)
on day two which lasted for three days. On the 4th day, the pain
began to subside and was completely gone by the 5th day. He has
been virtually pain-free since and is very happy with the increased
comfort with which he can begin each day. He can now comfortably
walk the golf course whereas before he was limited to a golf
cart. In February, 1997, he perceived a slight return of his
low back pain and decided to take another one-half course. He
experienced no breakthrough pain this time and is currently pain-free.
He has not taken any other medication for his back pain since
taking cetyl myristoleate initially.
Majesticia - She is an 85 year-old
lady who still works part-time at the family-owned business and
cares for her husband who has cancer. Majesticia was diagnosed
ten years ago with diabetes, and elevated triglycerides and cholesterol.
Overweight all her life, she is now stable at 265 pounds. She
suffers from long-standing osteoarthritis in her knees and ankles,
for which she was placed on cetyl myristoleate. No other agents
have been used by her for arthritis except for non-steroidal
anti-inflammatory drugs, both OTC and prescription. After about
7.6 grams of cetyl myristoleate, she was able to walk without
limping or experiencing significant pain. About three months
following the initial course, some pain returned, but she has
retained what she estimates to be 50% improvement. She also has
gallstones and a recurrent problem with gout, both of which have
been symptomless since her cetyl myristoleate course. She evidently
did not receive enough cetyl myristoleate for her body weight
and will be given another course of 13.25 grams.
Rose - Rose is a 46 year old
mother of four who works as a legal secretary. She was diagnosed
five years ago as having an atypical form of multiple sclerosis.
She had MRI exams of the skull and spinal cord, which demonstrated
several areas of non-specific degenerative changes in the brain
with several "bright spots" in the cervical spinal
cord. She had periodic visual aberrations as well as constant
fatigue and fibromyalgia-like pains focused in her trapezius
(bilaterally), and in her upper arms and legs below the knees.
She also complained of burning sensations in her hands and feet.
All of the symptoms worsened with elevated stress. There was
no sign of pernicious anemia or diabetes. She was receiving chiropractic
therapy. Joyce was started on numerous naturopathic therapies
in March, 1996 without significant benefit over an eight month
period. In November, 1996, she started on cetyl myristoleate
and indicated that she felt more fatigued for the first three
days but that the pain in her upper back and extremities was
completely gone. She further reported that the tingling/burning
sensation in her feet and hands was also gone. Rose felt this
was the most striking aspect of the treatment as those areas
were the ones most constantly affected. This improvement lasted
until she had to travel out of state to tend to her mother who
was diagnosed with a rapidly advancing malignancy. Over the next
three weeks, her symptoms began to reappear. After the death
of her mother, she returned home in as bad shape as before first
taking cetyl myristoleate. She decided that she wanted to take
another half course of cetyl myristoleate, which completely duplicated
the relief from the initial dosage with the exception that she
feels slightly less relief from her tendencies to fatigue than
she did after the first course. Rose will be taking another half
course to see if she can improve her stamina.
J.P. - He is a 60 year old male
who has been a farmer his entire life. Diagnosed with rheumatoid
arthritis 15 years ago, he has been on various pharmacologic
protocols during that time. The most recent includes Plaquenil,
methotrexate, and prednisone, with daily non-steroidal anti-inflammatory
drug dosing. J.P. has fusiform swelling involving most of the
joints of his fingers and moderate ulnar deviation of both hands.
He suffered severe pain most of the time which limited the labor
he could perform. He began cetyl myristoleate during the last
week of February, 1997, at which time he terminated his methotrexate
and Plaquenil (not recommended except in consultation with a
qualified physician). He has also reduced his prednisone from
15 milligrams per day to 5 mg, but he still maintains his NSAID
dosing on a daily basis. J.P. experienced a mild increase in
pain during the first four days of taking cetyl myristoleate,
but since then he has been pain free and the swelling in his
hands is reducing. J.P. will be monitored over the next month
to determine his stability, with checking of his serum parameters
by an MD. If he continues to remain symptom-free, his steroid
and NSAID therapies will be terminated. J.P. does not smoke,
eat chocolate, nor drink alcohol or caffeinated beverages. He
was advised at the onset of his cetyl myristoleate dosage to
avoid sugar. He is also taking Glucosaplex (a mix of glucosamines)
and Lyprinol (fatty acid extract of green lipped mussel) as an
additional natural anti-inflammatory agent.
First Page  Next
Page
CMO
or Cetyl Myristoleate for Arthritis Pain and Arthritic Conditions.
Ultimate CM Plus
|
A
target-specific exclusive formula, Ultimate